Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 9

1.

Temozolomide-induced inhibition of pituitary adenoma cells.

Sheehan J, Rainey J, Nguyen J, Grimsdale R, Han S.

J Neurosurg. 2011 Feb;114(2):354-8. doi: 10.3171/2010.4.JNS1024. Epub 2010 May 14.

PMID:
20469984
2.

Temozolomide in aggressive pituitary adenomas and carcinomas.

Ortiz LD, Syro LV, Scheithauer BW, Rotondo F, Uribe H, Fadul CE, Horvath E, Kovacs K.

Clinics (Sao Paulo). 2012;67 Suppl 1:119-23. Review.

3.

The role of temozolomide in the treatment of aggressive pituitary tumors.

Liu JK, Patel J, Eloy JA.

J Clin Neurosci. 2015 Jun;22(6):923-9. doi: 10.1016/j.jocn.2014.12.007. Epub 2015 Mar 12. Review.

PMID:
25772801
4.

Treatment of Aggressive Prolactin-Secreting Pituitary Adenomas with Adjuvant Temozolomide Chemotherapy: A Review.

Moisi M, Cruz AS, Benkers T, Rostad S, Broyles FB, Yuen K, Mayberg M.

Cureus. 2016 Jun 27;8(6):e658. doi: 10.7759/cureus.658. Review.

5.

Pituitary prolactin-secreting tumor formation: recent developments.

Xu RK, Wu XM, Di AK, Xu JN, Pang CS, Pang SF.

Biol Signals Recept. 2000 Jan-Feb;9(1):1-20. Review.

PMID:
10686432
6.

[Recent trends in the pathophysiology and treatment of pituitary adenomas].

Matsuno A.

Brain Nerve. 2009 Aug;61(8):957-62. Review. Japanese.

PMID:
19697885
7.

Leptin and the pituitary.

Sone M, Osamura RY.

Pituitary. 2001 Jan-Apr;4(1-2):15-23. Review.

PMID:
11824504
8.

Radiation therapy in the multimodal treatment approach of pituitary adenoma.

Becker G, Kocher M, Kortmann RD, Paulsen F, Jeremic B, Müller RP, Bamberg M.

Strahlenther Onkol. 2002 Apr;178(4):173-86. Review.

PMID:
12040754
9.

Treatment of pituitary neoplasms with temozolomide: a review.

Syro LV, Ortiz LD, Scheithauer BW, Lloyd R, Lau Q, Gonzalez R, Uribe H, Cusimano M, Kovacs K, Horvath E.

Cancer. 2011 Feb 1;117(3):454-62. doi: 10.1002/cncr.25413. Epub 2010 Sep 15. Review.

Supplemental Content

Support Center